These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27758762)

  • 1. Biomarkers of neuroendocrine tumors.
    d'Herbomez M; Coppin L; Bauters C; Rouaix-Emery N; Carnaille B; Do Cao C
    Ann Biol Clin (Paris); 2016 Dec; 74(6):669-679. PubMed ID: 27758762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic endocrine tumors: diagnostic pitfalls.
    Ectors N
    Hepatogastroenterology; 1999; 46(26):679-90. PubMed ID: 10370596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroendocrine tumors of the gastrointestinal tract].
    Arnold C
    Praxis (Bern 1994); 2007 Jan; 96(1-2):19-28. PubMed ID: 17256557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic endocrine tumors - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)].
    Kos-Kudła B; Bolanowski M; Hubalewska-Dydejczyk A; Krzakowski M; Marek B; Nasierowska-Guttmejer A; Lampe P; Sworczak K;
    Endokrynol Pol; 2008; 59(1):68-86. PubMed ID: 18335402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroendocrine tumors of the gastrointestinal-pancreatic system. Classification and diagnosis].
    Tiling N; Ricke J; Wiedenmann B
    Internist (Berl); 2002 Feb; 43(2):210-8. PubMed ID: 11963758
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulinoma: a rare neuroendocrine pancreatic tumor.
    Stamatakos M; Safioleas C; Tsaknaki S; Safioleas P; Iannescu R; Safioleas M
    Chirurgia (Bucur); 2009; 104(6):669-73. PubMed ID: 20187464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostics and treatment of neuroendocrine tumors of the digestive tract in the light of the present standards].
    Szczeblowska D
    Pol Merkur Lekarski; 2007 May; 22(131):437-41. PubMed ID: 17679390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors.
    Imamura M; Nakamoto Y; Uose S; Komoto I; Awane M; Taki Y
    J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):602-9. PubMed ID: 25624017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
    Goldin SB; Aston J; Wahi MM
    Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False positives and false negatives in neuroendocrine tumors diagnosis: clinical reports.
    Ducceschi M; Pusceddu S; Platania M
    Tumori; 2010; 96(5):827-32. PubMed ID: 21302640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of biomarker tests for diagnosis of neuroendocrine tumours.
    Hofland J; Zandee WT; de Herder WW
    Nat Rev Endocrinol; 2018 Nov; 14(11):656-669. PubMed ID: 30158549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Presentation and Diagnosis of Pancreatic Neuroendocrine Tumors.
    Anderson CW; Bennett JJ
    Surg Oncol Clin N Am; 2016 Apr; 25(2):363-74. PubMed ID: 27013370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry of neuroendocrine tumours.
    de Herder WW
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):33-41. PubMed ID: 17382264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in neuroendocrine neoplasms.
    Zouli C; Zisimopoulou E; Chrisoulidou A
    Hell J Nucl Med; 2023; 26 Suppl():44-48. PubMed ID: 37658563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine tumors of the digestive system].
    Prónai L; Rácz K; Tulassay Z
    Orv Hetil; 2002 May; 143(19 Suppl):1081-6. PubMed ID: 12063866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers.
    Verbeek WH; Korse CM; Tesselaar ME
    Eur J Endocrinol; 2016 Jan; 174(1):R1-7. PubMed ID: 26162406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors.
    Singh S; Law C
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):313-34. PubMed ID: 22646254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
    Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
    J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogranin A as a biochemical marker for the management of neuroendocrine tumors: a multicenter study developed in Argentina.
    Belli SH; Oneto A; Aranda C; O'Connor JM; Domenichini E; Roca E; Méndez G; Bestani MC; Parma P; Giacomi N; Marmissolle F
    Acta Gastroenterol Latinoam; 2009 Sep; 39(3):184-9. PubMed ID: 19845257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.